Fig. 2From: Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overviewTargeted delivery of drug and nanoparticles to OS by conjugating ligands and polymers (such as antibodies, BP, HPMA, and tetracycline) having high affinity towards boneBack to article page